Lehrstuhl für Genetik

CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance (2014) Nitschke L Journal article, Review article Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid. (2014) Schulze FS, Beckmann T, Nimmerjahn F, Ishiko A, Collin M, Koehl J, Goletz S, et al. Journal article SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders (2014) Simonetti G, Bertilaccio MTS, Rodriguez TV, Apollonio B, Dagklis A, Rocchi M, Innocenzi A, et al. Journal article A Balance between B Cell Receptor and Inhibitory Receptor Signaling Controls Plasma Cell Differentiation by Maintaining Optimal Ets1 Levels (2014) Luo W, Mayeux J, Gutierrez T, Russell L, Getahun A, Müller J, Tedder T, et al. Journal article Discovery of Multifold Modified Sialosides as Human CD22/Siglec-2 Ligands with Nanomolar Activity on B-Cells (2014) Prescher H, Schweizer A, Kuhfeldt E, Nitschke L, Brossmer R Journal article, Original article The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease (2014) Müller J, Nitschke L Journal article, Review article IN VIVO EFFECTS OF EPRATUZUMAB, A MONOCLONAL ANTIBODY TARGETING HUMAN CD22, ON B CELL FUNCTION IN HUMAN CD22 KNOCK-IN (HUKI) MICE (2014) Brandl C, Özgör L, Wöhner M, Shock A, Nitschke L Conference contribution The Ligand-Binding Domain of Siglec-G Is Crucial for Its Selective Inhibitory Function on B1 Cells (2014) Hutzler S, Özgör L, Naito-Matsui Y, Klaesener K, Winkler T, Reth M, Nitschke L Journal article, Original article Targeting B cells and autoantibodies in the therapy of autoimmune diseases. (2014) Kao D, Lux A, Schwab I, Nimmerjahn F Journal article, Review article Reply to - IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist. (2014) Schwab I, Lux A, Nimmerjahn F Journal article, other